Consistent with this finding, HCC patients with low miRNA-122-expressing tumors experienced relapse sooner than patients with high levels of miRNA-122, as did patients with high cyclin G-expressing tumors, further supporting the inverse correlation between the two. This evidence concerns the gene CCNG1 and hepatocellular carcinoma.